Replication and Pathology

Slides:



Advertisements
Similar presentations
Communicable Diseases. Figure 2.10: The Burden of Disease by Group of Cause, Percent of Deaths, 2001 Data from Lopez AD, et al Global Burden of Disease.
Advertisements

Yellow Fever Rob Sukumar, BIOL 402.
Avian Influenza - Pandemic Threat ? Reinhard Bornemann.
By Ryan Johnson. General Overview  NTD  >20% of human population infected  Locally underestimated  Public health crucial.
Hepatitis B.
S4 Infectious Disease Group Presentation : Influenza Group 2:EMMY Tang JACKY Ng KENNETH Ho LAURA Chow.
Influenza Michelle Lin.
Curriculum Development Infectious Diseases Assumptions Students may not have M.D. Goal To enable students to identify problems, investigate, and control.
Malaria By Marlee Shaw. Vector born infectious vector born carried by mosquitoes Vector born infectious vector born carried by mosquitoes Carried by female.
Virion Structure and Organization
Pharmaceutical Composition Claims and Enablement Robert J. Hill, Jr. Quality Assurance Specialist Technology Center
Journal 1/16 What do you know about infectious and non- infectious diseases? What do you think the difference is? How could a person prevent getting the.
ROTAVIRUS KEVIN ELMORE BIOL 402 POSTER PROJECT PRESENTATION.
RESULTS Division of Arboviruses, Center for Immunology and Pathology, National Institute of Health, Korea Centers for disease control, Osong, Korea BACKGROUND.
Early neutralizing IgG response to Chikungunya virus in infected patients targets a dominant linear epitope on the E2 glycoprotein by Yiu ‐ Wing Kam, Fok.
Enterococcus faecalis Induces Inflammatory Bowel Disease in Interleukin-10 Knockout Mice Edward Balish, Thomas Warner The American Journal of Pathology.
Date of download: 7/9/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Breastfeeding of Newborns by Mothers Carrying Hepatitis.
By: Sam Levinson and Arielle Ackerlund Block: 3/A.
Publish Date : January 2017 No. of Pages : 87 Geography Coverage : Global Price for Single User Licence : USD 900 Price for Global.
Zika Virus Vaccines Industry Competitive Landscape Analysis
DISEASE: Pathogen name that causes the disease: Student Name:
Copyright © 2017 American Academy of Pediatrics.
Viruses Chapter 19.
Additional Slide The graph can be used to explain that the symptoms of a vector born disease usually do not occur immediately when you are bitten. The.
Copyright © 2017 American Academy of Pediatrics.
Copyright © 2011 American Medical Association. All rights reserved.
WHO Ebola Control Center Conakry Preparedness neighboring countries
Diagnosis: Treatment: Introduction: Prevention: Pathogenesis:
intervals from six months to one year
Copyright © 2017 American Academy of Pediatrics.
Warm-up Why do many scientists classify viruses as non-living?
Yellow Fever.
Clinical Manifestations and Epidemiology
CDC Guidelines for Use of QuantiFERON®-TB Gold Test
KEY CONCEPT Some viral diseases can be prevented with vaccines.
Disease Transmission Deer mouse (spreads hantavirus)
Yellow Fever Lauren Bauer.
بیا تا چرخ نیلو را عمل در عالم اندازیم
Viruses Chapter 19.
Approach to diagnosis of infective endocarditis
VIRUSES!.
A Prize for Cancer Prevention
Viruses and Cancer.
J.-P. Van geertruyden  Clinical Microbiology and Infection 
Virological tools to diagnose and monitor hepatitis C virus infection
What is Epidemiology? Epidemiology is the study of patterns of health, illness and associated factors at the population level. Epidemiologists study the.
Projected new adult infections and total adult deaths in sub-Saharan Africa, in millions, by the year 2020: Impact of three scenarios compared to baseline.
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
Re-Emergence of Zika Virus: A Review on Pathogenesis, Clinical Manifestations, Diagnosis, Treatment, and Prevention  Waqas Shuaib, MD, Hashim Stanazai,
Control of immunopathology during chikungunya virus infection
Urbanization and geographic expansion of zoonotic arboviral diseases: mechanisms and potential strategies for prevention  Scott C. Weaver  Trends in Microbiology 
Homework #1 is posted and due 9/17
Performance of hepatitis C virus (HCV) direct-acting antivirals in clinical trials and daily practice  J.E. Arends, P.A.M. Kracht, A.I.M. Hoepelman  Clinical.
Zika Virus in the Americas: A Review for Clinicians
S. Kurath, G. Halwachs-Baumann, W. Müller, B. Resch 
Nonhematopoietic cells help regulate the pathogenic adaptive immune response during the second peak of joint swelling. Nonhematopoietic cells help regulate.
CD4 T cells are responsible for the intensified joint pathology at 6 d postinfection. CD4 T cells are responsible for the intensified joint pathology at.
Transfusion-transmitted virus infection in HIV-1-seropositive patients
New developments in laboratory monitoring of HIV-1 infection
TNFα-producing CD3+CD4+CD44+ infiltrating cells.
Reducing antibiotic use in influenza: challenges and rewards
Zika virus infection during pregnancy: what, where, and why?
Molecular virology and immunology of HIV infection
March 2 Goal: Objective: SWBAT Class work:
21.1 Journal Directions DO NOT WRITE ON THESE PAGES
Target disease and target populations for 21st century vaccine developmentIncluded in the list are the agents of infectious diseases for which vaccines.
Urbanization and geographic expansion of zoonotic arboviral diseases: mechanisms and potential strategies for prevention  Scott C. Weaver  Trends in Microbiology 
Viruses.
KEY CONCEPT Some viral diseases can be prevented with vaccines.
KEY CONCEPT Some viral diseases can be prevented with vaccines.
Presentation transcript:

Replication and Pathology Chikungunya Virus Sarah Chen | BIOL402 Infectious Disease in the Developing World The Virus Replication and Pathology Viperin restricts chikungunya virus replication and pathology. Teng et al 2012 Alphavirus Structural proteins & nonstructural proteins Figure 2. Viperin controls CHIKV infection in mice in vitro. Figure 1. Overexpression of viperin controls CHIKV replication. The Disease Epidemiology References Chikunguya virus and the global spread of mosquito-borne disease. Weaver and Lecuit 2015 Center for Disease Control and Prevention. Chikungunya Virus [Internet]. Available from: http://www.cdc.gov/chikungunya/ Simizu B, Yamamoto K, Ogata T, Hashimoto K. 1984. Structural proteins of Chikungunya virus Journal of Virology. Journal of Virology 51:254–258. Teng TS, Foo S, Chin K, Ng L, Teo T, Lulla A, Yeo NK, Koh EG, Chow A, Leo Y, et al. 2012. Viperin restricts chikungunya virus replication and pathology. Journal of Clinical Investigation. Journal of Clinical Investigation 122:4447–4460. Weaver SC, Osorio JE, Livengood JA, Chen R, Stinchcomb DT. 2012. Chikungunya virus and prospects for a vaccine Expert Review of Vaccines. Expert Review of Vaccines 11:1087–1101. Symptoms Transmission Treatment & vs prevention